First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Reaches New 52-Week High – What’s Next?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) shares hit a new 52-week high during trading on Tuesday . The company traded as high as $272.91 and last traded at $272.02, with a volume of 49511 shares. The stock had previously closed at $268.96.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

The company has a market capitalization of $3.00 billion, a P/E ratio of 21.72 and a beta of 0.66. The firm has a 50 day moving average price of $251.39 and a two-hundred day moving average price of $223.15.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Several institutional investors have recently bought and sold shares of FBT. Russell Investments Group Ltd. lifted its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock valued at $29,000 after acquiring an additional 158 shares during the period. AG Campbell Advisory LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at $31,000. Cassaday & Co Wealth Management LLC bought a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the 1st quarter worth about $34,000. Continuum Advisory LLC bought a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the 2nd quarter worth about $35,000. Finally, Parallel Advisors LLC increased its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 1,300.0% during the 1st quarter. Parallel Advisors LLC now owns 182 shares of the company’s stock worth $37,000 after purchasing an additional 169 shares in the last quarter.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.